Trial · NCT03291379
Results by group107
Each measurement the trial posted, group by group, in the words and numbers it posted.
61 to 80 of 107
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 08 (inferior lesion): N-desmethyl concentration centre of tumour | 80.2 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 08: N-desmethyl Vandetanib concentration middle of tumour | 57.1 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 08 (inferior lesion): N-desmethyl Vandetanib concentration middle of tumour | 101 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 08: N-desmethyl Vandetanib concentration edge of tumour | 145 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 08 (inferior lesion): N-desmethyl Vandetanib concentration edge of tumour | 171 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 08: N-desmethyl Vandetanib concentration 1cm away from tumour | 389 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 08 (1 cm lesion): N-desmethyl Vandetanib concentration 1cm away from tumour | 342 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 08 (inferior lesion): N-desmethyl Vandetanib concentration 1cm away from tumour | 405 | ng/mL | |
| Evaluate the Anatomical Distribution of BTG-002814 on Non-contrast Enhanced Imaging Using 4D CT | BTG-002814 | Subject 01: Liver | 928.83 | µL | |
| Evaluate the Anatomical Distribution of BTG-002814 on Non-contrast Enhanced Imaging Using 4D CT | BTG-002814 | Subject 01: Registered sample | 399.27 | µL | |
| Evaluate the Anatomical Distribution of BTG-002814 on Non-contrast Enhanced Imaging Using 4D CT | BTG-002814 | Subject 01: Tumour | 361.14 | µL | |
| Evaluate the Anatomical Distribution of BTG-002814 on Non-contrast Enhanced Imaging Using 4D CT | BTG-002814 | Subject 01: tumour dilated 1cm | 393.79 | µL | |
| Evaluate the Anatomical Distribution of BTG-002814 on Non-contrast Enhanced Imaging Using 4D CT | BTG-002814 | Subject 01: Tumour dilated 2cm | 479.28 | µL | |
| Evaluate the Anatomical Distribution of BTG-002814 on Non-contrast Enhanced Imaging Using 4D CT | BTG-002814 | Subject 02: Liver | 764.69 | µL | |
| Evaluate the Anatomical Distribution of BTG-002814 on Non-contrast Enhanced Imaging Using 4D CT | BTG-002814 | Subject 02: Tumour | 596.78 | µL | |
| Evaluate the Anatomical Distribution of BTG-002814 on Non-contrast Enhanced Imaging Using 4D CT | BTG-002814 | Subject 02: Tumour dilated 1cm | 617.72 | µL | |
| Evaluate the Anatomical Distribution of BTG-002814 on Non-contrast Enhanced Imaging Using 4D CT | BTG-002814 | Subject 02: Tumour dilated 2cm | 649.97 | µL | |
| Evaluate the Anatomical Distribution of BTG-002814 on Non-contrast Enhanced Imaging Using 4D CT | BTG-002814 | Subject 03: Liver | 594.79 | µL | |
| Evaluate the Anatomical Distribution of BTG-002814 on Non-contrast Enhanced Imaging Using 4D CT | BTG-002814 | Subject 03: Registered sample | 116.54 | µL | |
| Evaluate the Anatomical Distribution of BTG-002814 on Non-contrast Enhanced Imaging Using 4D CT | BTG-002814 | Subject 03: Tumour | 0.32 | µL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03291379/results?page=4